Emerald Mutual Fund Advisers Trust’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-114
Closed -$2.82M – 295
2015
Q3
$2.82M Buy
114
+97
+571% +$6.53M 0.18% 139
2015
Q2
$1.42M Buy
+17
New +$1.56M 0.11% 154
2015
Q1
– Sell
-29
Closed -$3.72M – 233
2014
Q4
$3.72M Sell
29
-46
-61% -$3.37M 0.32% 96
2014
Q3
$3.66M Hold
75
– – 0.35% 94
2014
Q2
$2.02M Buy
75
+29
+63% +$684K 0.19% 122
2014
Q1
$1.2M Buy
+46
New +$1.3M 0.12% 144

Other funds holding TPST

Emerald Mutual Fund Advisers Trust's TPST Position: Q4 2015 in Review

Emerald Mutual Fund Advisers Trust sold out of Tempest Therapeutics (TPST) in Q4 2015, closing a stake of 114 shares — an estimated $2.82M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TPST in Q1 2014 and held it in 6 quarters. The position peaked at $3.72M in Q4 2014. 78 funds tracked by Wall St. Rank hold TPST as of Q4 2015.

  • Emerald Mutual Fund Advisers Trust reported no remaining Tempest Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 114 Tempest Therapeutics shares in Q4 2015, an estimated $2.82M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Tempest Therapeutics in Q1 2014 and held it in 6 quarters.
  • Emerald Mutual Fund Advisers Trust's Tempest Therapeutics position peaked at $3.72M in Q4 2014.
  • 78 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2015.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2015, filed 25 Jan 2016.